256 related articles for article (PubMed ID: 17719584)
21. Phytosphingosine-1-phosphate stimulates chemotactic migration of L2071 mouse fibroblasts via pertussis toxin-sensitive G-proteins.
Kim MK; Park KS; Lee H; Kim YD; Yun J; Bae YS
Exp Mol Med; 2007 Apr; 39(2):185-94. PubMed ID: 17464180
[TBL] [Abstract][Full Text] [Related]
22. Clusterin stimulates the chemotactic migration of macrophages through a pertussis toxin sensitive G-protein-coupled receptor and Gβγ-dependent pathways.
Kang BH; Shim YJ; Tae YK; Song JA; Choi BK; Park IS; Min BH
Biochem Biophys Res Commun; 2014 Mar; 445(3):645-50. PubMed ID: 24569077
[TBL] [Abstract][Full Text] [Related]
23. Collagen-binding motif peptide, a cleavage product of osteopontin, stimulates human neutrophil chemotaxis via pertussis toxin-sensitive G protein-mediated signaling.
Kim MK; Kim SD; Lee HY; Lee SY; Shim JW; Yun J; Kim JM; Min do S; Yoo YH; Bae YS
FEBS Lett; 2008 Oct; 582(23-24):3379-84. PubMed ID: 18804464
[TBL] [Abstract][Full Text] [Related]
24. LPA1 receptors mediate stimulation, whereas LPA2 receptors mediate inhibition, of migration of pancreatic cancer cells in response to lysophosphatidic acid and malignant ascites.
Komachi M; Tomura H; Malchinkhuu E; Tobo M; Mogi C; Yamada T; Kimura T; Kuwabara A; Ohta H; Im DS; Kurose H; Takeyoshi I; Sato K; Okajima F
Carcinogenesis; 2009 Mar; 30(3):457-65. PubMed ID: 19129242
[TBL] [Abstract][Full Text] [Related]
25. Lysophosphatidic acid induces prostate cancer PC3 cell migration via activation of LPA(1), p42 and p38alpha.
Hao F; Tan M; Xu X; Han J; Miller DD; Tigyi G; Cui MZ
Biochim Biophys Acta; 2007 Jul; 1771(7):883-92. PubMed ID: 17531530
[TBL] [Abstract][Full Text] [Related]
26. The G12/13-RhoA signaling pathway contributes to efficient lysophosphatidic acid-stimulated cell migration.
Bian D; Mahanivong C; Yu J; Frisch SM; Pan ZK; Ye RD; Huang S
Oncogene; 2006 Apr; 25(15):2234-44. PubMed ID: 16301993
[TBL] [Abstract][Full Text] [Related]
27. Lysophosphatidic acid induction of vascular endothelial growth factor expression in human ovarian cancer cells.
Hu YL; Tee MK; Goetzl EJ; Auersperg N; Mills GB; Ferrara N; Jaffe RB
J Natl Cancer Inst; 2001 May; 93(10):762-8. PubMed ID: 11353786
[TBL] [Abstract][Full Text] [Related]
28. Dual mechanisms for lysophosphatidic acid stimulation of human ovarian carcinoma cells.
Hu YL; Albanese C; Pestell RG; Jaffe RB
J Natl Cancer Inst; 2003 May; 95(10):733-40. PubMed ID: 12759391
[TBL] [Abstract][Full Text] [Related]
29. Lysophosphatidic acid induces hypertrophy of neonatal cardiac myocytes via activation of Gi and Rho.
Hilal-Dandan R; Means CK; Gustafsson AB; Morissette MR; Adams JW; Brunton LL; Heller Brown J
J Mol Cell Cardiol; 2004 Apr; 36(4):481-93. PubMed ID: 15081308
[TBL] [Abstract][Full Text] [Related]
30. Characterization of a neuronal cell line expressing native human melanin-concentrating hormone receptor 1 (MCHR1).
Fry D; Dayton B; Brodjian S; Ogiela C; Sidorowicz H; Frost LJ; McNally T; Reilly RM; Collins CA
Int J Biochem Cell Biol; 2006; 38(8):1290-9. PubMed ID: 16524757
[TBL] [Abstract][Full Text] [Related]
31. Lysophosphatidic acid induces human natural killer cell chemotaxis and intracellular calcium mobilization.
Jin Y; Knudsen E; Wang L; Maghazachi AA
Eur J Immunol; 2003 Aug; 33(8):2083-9. PubMed ID: 12884281
[TBL] [Abstract][Full Text] [Related]
32. Lysophosphatidic acid (LPA) in malignant ascites stimulates motility of human pancreatic cancer cells through LPA1.
Yamada T; Sato K; Komachi M; Malchinkhuu E; Tobo M; Kimura T; Kuwabara A; Yanagita Y; Ikeya T; Tanahashi Y; Ogawa T; Ohwada S; Morishita Y; Ohta H; Im DS; Tamoto K; Tomura H; Okajima F
J Biol Chem; 2004 Feb; 279(8):6595-605. PubMed ID: 14660630
[TBL] [Abstract][Full Text] [Related]
33. Luteinizing hormone-induced up-regulation of ErbB-2 is insufficient stimulant of growth and invasion in ovarian cancer cells.
Warrenfeltz SW; Lott SA; Palmer TM; Gray JC; Puett D
Mol Cancer Res; 2008 Nov; 6(11):1775-85. PubMed ID: 19010824
[TBL] [Abstract][Full Text] [Related]
34. Endogenous RGS proteins attenuate Galpha(i)-mediated lysophosphatidic acid signaling pathways in ovarian cancer cells.
Hurst JH; Henkel PA; Brown AL; Hooks SB
Cell Signal; 2008 Feb; 20(2):381-9. PubMed ID: 18083345
[TBL] [Abstract][Full Text] [Related]
35. Expression profile of heptahelical putative membrane progesterone receptors in epithelial ovarian tumors.
Romero-Sánchez M; Peiper SC; Evans B; Wang Z; Catasús L; Ribe A; Prat J; Giri JG
Hum Pathol; 2008 Jul; 39(7):1026-33. PubMed ID: 18479732
[TBL] [Abstract][Full Text] [Related]
36. Insulin receptor substrate-1 is an important mediator of ovarian cancer cell growth suppression by all-trans retinoic acid.
Ravikumar S; Perez-Liz G; Del Vale L; Soprano DR; Soprano KJ
Cancer Res; 2007 Oct; 67(19):9266-75. PubMed ID: 17909034
[TBL] [Abstract][Full Text] [Related]
37. Ovarian cancer G protein-coupled receptor 1, a new metastasis suppressor gene in prostate cancer.
Singh LS; Berk M; Oates R; Zhao Z; Tan H; Jiang Y; Zhou A; Kirmani K; Steinmetz R; Lindner D; Xu Y
J Natl Cancer Inst; 2007 Sep; 99(17):1313-27. PubMed ID: 17728215
[TBL] [Abstract][Full Text] [Related]
38. Stimulation of early gene induction and cell proliferation by lysophosphatidic acid in human amnion-derived WISH cells: role of phospholipase D-mediated pathway.
Kim JI; Jo EJ; Lee HY; Kang HK; Lee YN; Kwak JY; Bae YS
Biochem Pharmacol; 2004 Jul; 68(2):333-40. PubMed ID: 15194005
[TBL] [Abstract][Full Text] [Related]
39. [Lysophosphatidic acid (LPA) stimulates invasion and metastatic colonization of ovarian cancer cells through Rac activation].
Yu X; Zhang Y; Chen H
Zhonghua Zhong Liu Za Zhi; 2015 Feb; 37(2):95-100. PubMed ID: 25975684
[TBL] [Abstract][Full Text] [Related]
40. Action and Signaling of Lysophosphatidylethanolamine in MDA-MB-231 Breast Cancer Cells.
Park SJ; Lee KP; Im DS
Biomol Ther (Seoul); 2014 Feb; 22(2):129-35. PubMed ID: 24753818
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
